KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Preferred Dividend Payments (2017 - 2021)

Arbutus Biopharma's Preferred Dividend Payments history spans 5 years, with the latest figure at $574000.0 for Q4 2021.

  • For Q4 2021, Preferred Dividend Payments fell 81.62% year-over-year to $574000.0; the TTM value through Sep 2022 reached $574000.0, down 96.09%, while the annual FY2021 figure was $12.1 million, 0.13% changed from the prior year.
  • Preferred Dividend Payments for Q4 2021 was $574000.0 at Arbutus Biopharma, down from $5.1 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $5.1 million in Q3 2021 and bottomed at $574000.0 in Q4 2021.
  • The 5-year median for Preferred Dividend Payments is $2.8 million (2019), against an average of $2.7 million.
  • The largest YoY upside for Preferred Dividend Payments was 68.05% in 2021 against a maximum downside of 81.62% in 2021.
  • A 5-year view of Preferred Dividend Payments shows it stood at $911000.0 in 2017, then surged by 181.78% to $2.6 million in 2018, then grew by 12.19% to $2.9 million in 2019, then rose by 8.44% to $3.1 million in 2020, then plummeted by 81.62% to $574000.0 in 2021.
  • Per Business Quant, the three most recent readings for ABUS's Preferred Dividend Payments are $574000.0 (Q4 2021), $5.1 million (Q3 2021), and $3.3 million (Q2 2021).